The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors

INTRODUCTION: To retrospectively evaluate the impact of comorbidities on treatment choice, 12-month clinical response, and 24-month retention rate in a cohort of patients with rheumatoid arthritis (RA) treated with a first-line tumor necrosis factor alpha inhibitor (TNFi), by using for the first tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Biggioggero, Martina, Mesina, Federica, Favalli, Ennio Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348828/
https://www.ncbi.nlm.nih.gov/pubmed/30733963
http://dx.doi.org/10.1155/2019/6107217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348828/
https://www.ncbi.nlm.nih.gov/pubmed/30733963
http://dx.doi.org/10.1155/2019/6107217

Ejemplares similares